back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-10-12 14:17 Tx date 2019-10-08 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,282.50
-9,500 vol $0.135 each |
600,500 | |
| Filed 2019-10-10 13:46 Tx date 2019-10-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,506
+2,000 vol $4.25 each |
2,000 | |
| Filed 2019-09-27 20:13 Tx date 2019-09-27 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-67.50
-500 vol $0.135 each |
610,000 | |
| Filed 2019-09-27 20:12 Tx date 2019-09-26 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,250
-50,000 vol $0.125 each |
610,500 | |
| Filed 2019-09-27 20:11 Tx date 2019-09-24 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,250
-10,000 vol $0.125 each |
660,500 | |
| Filed 2019-09-27 20:10 Tx date 2019-09-23 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,700
-20,000 vol $0.135 each |
670,500 | |
| Filed 2019-07-03 12:56 Tx date 2019-07-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,772.97
-1,483 vol $6.59 each |
0 | |
| Filed 2019-02-02 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$703,499
+87,500 vol $8.04 each |
295,695 | |
| Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-305,320.8299
-48,611 vol $6.28 each |
1,483 | |
| Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-60,189.8647
-9,583 vol $6.28 each |
1,483 | |
| Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-8,111 vol |
217,778 | |
| Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$40,344
+9,583 vol $4.21 each |
11,066 | |
| Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-48,611 vol |
225,889 | |
| Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$32,038
+8,111 vol $3.95 each |
9,594 | |
| Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$316,943
+48,611 vol $6.52 each |
50,094 | |
| Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$60,189
+9,583 vol $6.28 each |
||
| Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-50,944.3799
-8,111 vol $6.28 each |
1,483 | |
| Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-9,583 vol |
208,195 | |
| Filed 2018-10-15 Tx date 2018-10-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Rashieda Gluck I.R.A. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,402
-600 vol $5.67 each |
0 | |
| Filed 2018-10-15 Tx date 2018-10-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,695
-4,500 vol $5.71 each |
0 | |
| Filed 2018-10-15 Tx date 2018-10-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Franklin T Gluck I.R.A. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,690
-1,000 vol $5.69 each |
0 | |
| Filed 2018-06-20 Tx date 2018-06-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,172
+700 vol $5.96 each |
4,500 | |
| Filed 2018-06-12 Tx date 2018-06-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
-1,483 vol |
0 | |
| Filed 2018-06-12 Tx date 2018-06-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,660
+3,800 vol $5.70 each |
3,800 | |
| Filed 2018-06-12 Tx date 2016-01-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Rashieda Gluck I.R.A. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
600 | ||
| Filed 2018-06-12 Tx date 2016-01-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Franklin T Gluck I.R.A. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000 | ||
| Filed 2018-06-12 Tx date 2018-06-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,107
+1,483 vol $2.77 each |
1,483 | |
| Filed 2018-06-01 Tx date 2018-06-01 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
75,000 | |
| Filed 2018-06-01 Tx date 2018-05-17 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-05-31 Tx date 2018-05-17 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
690,500 | ||
| Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-40,000 vol |
320,000 | |
| Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$90,850
+23,000 vol $3.95 each |
88,000 | |
| Filed 2018-05-21 Tx date 2018-03-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,290
-1,000 vol $5.29 each |
0 | |
| Filed 2018-05-21 Tx date 2018-03-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,850
-4,500 vol $5.30 each |
0 | |
| Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$129,750
+25,000 vol $5.19 each |
25,000 | |
| Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$135,600
+40,000 vol $3.39 each |
65,000 | |
| Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$94,725
+22,500 vol $4.21 each |
110,500 | |
| Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-616,308
-101,200 vol $6.09 each |
9,300 | |
| Filed 2018-05-21 Tx date 2018-05-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-56,525.40
-9,300 vol $6.08 each |
0 | |
| Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-129,750
-25,000 vol $5.19 each |
360,000 | |
| Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-23,000 vol |
297,000 | |
| Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-22,500 vol |
274,500 | |
| Filed 2018-02-07 Tx date 2018-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,141,000
+175,000 vol $6.52 each |
385,000 | |
| Filed 2018-02-03 Tx date 2018-01-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,640
+500 vol $5.28 each |
1,000 | |
| Filed 2018-02-03 Tx date 2018-01-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,760
+500 vol $5.52 each |
500 | |
| Filed 2017-11-29 Tx date 2017-11-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,351
+263 vol $5.14 each |
4,500 | |
| Filed 2017-07-21 Tx date 2017-07-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,160
-2,000 vol $7.08 each |
4,237 | |
| Filed 2017-05-03 Tx date 2017-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,499
+50,000 vol $9.45 each |
210,000 | |
| Filed 2017-02-15 Tx date 2017-02-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-3.75
-15 vol $0.25 each |
160,000 | |
| Filed 2017-02-15 Tx date 2017-02-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-2.00
-10 vol $0.20 each |
160,015 | |
| Filed 2017-02-10 Tx date 2017-02-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+55,000 vol |
160,025 | |
| Filed 2017-01-27 Tx date 2017-01-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-5.00
-25 vol $0.20 each |
105,025 | |
| Filed 2017-01-27 Tx date 2017-01-24 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,835
-3,000 vol $2.94 each |
6,237 | |
| Filed 2017-01-12 Tx date 2017-01-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$5.00
+50 vol $0.10 each |
105,050 | |
| Filed 2017-01-03 Tx date 2017-01-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,180
+2,000 vol $2.09 each |
9,237 | |
| Filed 2016-07-28 Tx date 2016-07-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
105,000 | |
| Filed 2016-07-28 Tx date 2016-07-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,545
-1,500 vol $3.03 each |
0 | |
| Filed 2016-06-23 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+1,483 vol |
1,483 | |
| Filed 2016-06-23 Tx date 2016-01-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-23 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$9,999
+4,237 vol $2.36 each |
7,237 | |
| Filed 2016-03-28 Tx date 2016-03-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,500
-1,500 vol $3.00 each |
1,500 | |
| Filed 2016-01-21 Tx date 2016-01-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,686
+1,000 vol $1.69 each |
3,000 | |
| Filed 2016-01-21 Tx date 2016-01-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,900
+1,000 vol $2.90 each |
3,000 | |
| Filed 2016-01-12 Tx date 2016-01-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000 | ||
| Filed 2016-01-12 Tx date 2016-01-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
65,000 | ||
| Filed 2016-01-12 Tx date 2016-01-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000 |